OliX Pharmaceuticals Commences Patient Dosing in Phase 1 Clinical Trial of OLX75016 for MASH

- Australia phase 1 clinical trials on 70 healthy + NAFLD participants

Related Keywords

Australia ,Brisbane ,Queensland ,Jiyoun Kim ,Gip Olix Pharmaceuticals Inc ,Wide Association Study ,Olix Pharmaceuticals ,Genome Wide Association Study ,Chief Executive Officer ,Press Release , ,